Effects of hypertension and type 2 diabetes mellitus on the risk of total cardiovascular events in Japanese patients with hypercholesterolemia: Implications from the Japan Lipid Intervention Trial (J-LIT)

Hypertension Research

Volumn 30, Issue 2, 2007, Pages 119-123

  Shimamoto, Kazuaki ^a   Kita, Toru ^b   Mabuchi, Hiroshi ^c   Matzuzaki, Masunori ^d   Matsuzawa, Yuji ^e   Nakaya, Noriaki ^f   Oikawa, Shinichi ^g   Saito, Yasushi ^h   Sasaki, Jun ⁱ   Itakura, Hiroshige ^j  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^d YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SUMITOMO HOSPITAL   (Japan)

^f Nakaya Clinic   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^j IBARAKI CHRISTIAN UNIVERSITY   (Japan)

more..

Author keywords

Cardiovascular events; Diabetes mellitus; Hyperlipidemia; Hypertension; Simvastatin

Indexed keywords

SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PATIENT COMPLIANCE; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; JAPAN; MALE; MIDDLE AGED;

EID: 34047234580     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.119     Document Type: Article

References (22)

1. Howard BV, Rodrigues BL, Bennett PH, et al: Diabetes and cardiovascular disease: Writing Group I: epidemiology. Circulation 2002; 105: e132-e137.
2. Goldstein LB, Adams R, Becker K, et al: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001; 103: 163-182.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
4. Fujishima M, Kiyohara Y, Kato I, et al: Diabetes and cardiovascular disease in a prospective population survey in Japan: the Hisayama Study. Diabetes 1996; 45: S14-S16.
5. Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976; 38: 46-51.
6. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153: 598-615.
7. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas AM, Thorvaldsen P, Tuomilehto J: Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project: an ecological study of 18 populations. Stroke 1997; 28: 1367-1374.
8. He J, Whelton PK: Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J 1999; 138: 211-219.
9. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
10. Guidelines Sub-Committee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
11. Hansson L, Zanchetti A, Carruther SG, et al, HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-1762.
12. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
13. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
14. Matsuzawa Y, Itakura H, Kita T, et al: Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan Lipid Intervention Trial (J-LIT). Curr Ther Res 2000; 61: 219-243.
15. Matsuzawa Y, Kita T, Mabuchi H, et al: Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. Circ J 2003; 67: 287-294.
16. Matsuzaki M, Kita T, Mabuchi H, et al: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: 1087-1095.
17. Oikawa S, Kita T, Mabuchi H, et al: Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT). Atherosclerosis 2007 (in press, online available).
18. Nakaya N, Kita T, Mabuchi H, et al: Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT). Circ J 2005; 69: 1016-1021.
19. Kuzuya T, Nakagawa S, Satoh J, et al: Report of the Committee of Japan Diabetes Society on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Jpn Diab Soc 1999; 42: 385-404.
20. Shimamoto K, Kita T, Mabuchi H, et al: The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) study, a large-scale observational cohort study. Hypertens Res 2005; 28: 879-887.
21. Arauz-Pacheco C, Parrott MA, Raskin P: Hypertension management in adults with diabetes. Diabetes Care 2004; 27: S65-S67.
22. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.